TULUA 脂肪腹壁成形术:横形筋膜折叠、不分离皮瓣与无限制吸脂的多中心 845 例研究
TULUA 是一种不分离皮瓣、行横形筋膜折叠与无限制吸脂的脂肪腹壁成形术。该多中心回顾性研究纳入 10 国 68 位术者共 845 例患者,平均美学评分 8.68/10,总体并发症率 16.2%,以血清肿为主(8.8%),血管相关并发症 2.7%,无死亡。吸烟与肥胖使并发症风险翻倍,加之年龄>60 岁风险增加 7–9 倍。
要点
- TULUA 技术不分离皮瓣、横形折叠筋膜并允许无限制吸脂,总体并发症率 16.2%。
- 吸烟与肥胖使并发症风险翻倍,若合并年龄>60 岁风险增加 7–9 倍。
- 血清肿最常见(8.8%),血管相关并发症仅 2.7%,无死亡,美学评分平均 8.68/10。
核心结论
- TULUA 脂肪腹壁成形术是可重复的新术式,量化结果良好且并发症率可接受。
研究设计与样本
- 多中心回顾性研究,由 10 个国家 68 位整形外科医生提供 845 例患者数据。
- 美学结果由每位术者采用 Salles 量表评分,并与并发症结合分析患者与手术特征的关联。
- 证据等级为治疗性 IV 级。
主要发现
- 患者中 95.5% 为女性,19.7% 肥胖,35.6% 有既往瘢痕,10.4% 既往腹壁成形术,6.5% 减重术后,6.6% 吸烟,16.5% 有合并症,1 例肾移植。
- 手术特征平均为吸脂量 2967 ml、切除量 1388 g、手术时间 3.9 小时,46.5% 未住院。
- 平均美学评分 8.68/10,瘢痕与脐位置比例适当,无上腹代偿性膨出(4.97/6)。
- 总体并发症率 16.2%,最常见为血清肿 8.8%,血管相关并发症(坏死、伤口裂开、感染)为 2.7%,无死亡。
- 逻辑回归显示吸烟与肥胖使并发症风险翻倍;若加上年龄>60 岁,并发症风险增加 7–9 倍。
关键数值与推荐
- 报告适应证多样,但排除病理性腹直肌分离。
临床怎么用
- TULUA 可作为脂肪腹壁成形术的可重复术式,术前应评估吸烟、肥胖及年龄>60 岁以分层并发症风险。
- 术后需重点关注血清肿,血管相关并发症发生率较低。
局限性
- 为回顾性多中心研究,证据等级 IV 级。
- 美学结果由术者自评 Salles 量表,可能存在评价偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: TULUA (transverse plication, no undermining, full liposuction, neoumbilicoplasty, and low transverse abdominal scar) is the acronym for a radically different lipoabdominoplasty, intended to add simplicity, improve vascular safety, and attain good results. Modifications are unrestricted liposuction, no flap detachment, massive transverse infraumbilical plication, umbilicus amputation, neoumbilicoplasty, diminished tension wound closure, and low transverse scar settlement. The objectives of this article are to describe the technique and analyze a multicenter experience. METHODS: Sixty-eight plastic surgeons from 10 countries provided data for a retrospective review of 845 patients. Aesthetic results were scored by each surgeon using the Salles scale and analyzed in combination with complications to identify associations between patient and surgery characteristics. RESULTS: Of the patients, 95.5 percent were female, 19.7 percent were obese, 35.6 percent had prior scars, 10.4 percent had undergone previous abdominoplasty, 6.5 percent were postbariatric, and 6.6 percent were smokers. One patient had a kidney transplant, and 16.5 percent had comorbidities. Surgery characteristics varied widely, being on average as follows: lipoaspirate, 2967 ml; resection, 1388 g; and surgical time, 3.9 hours; 46.5 percent were not hospitalized. Averaged results were 8.68 of 10 points, besides adequate positioning and proportion of scar and umbilicus, without epigastric compensatory bulging (4.97 of 6 points). Overall complications were 16.2 percent, mostly seroma (8.8 percent); vascular-related complications (i.e., necrosis, wound dehiscence, and infection) constituted 2.7 percent. There were no fatalities. The logistic regression model demonstrated that smoking and obesity duplicate the risk of complications; if age older than 60 years is added, the risk of complication increases seven to nine times. Reported indications were multiple; however, pathologic diastasis was excluded. CONCLUSION: TULUA lipoabdominoplasty is a new reproducible procedure with good quantified results and an acceptable complication rate. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
引用
- Villegas-Alzate FJ, Blugerman G, Vera-Cucchiaro J, et al. TULUA Lipoabdominoplasty: Transversal Aponeurotic Plication, No Undermining, and Unrestricted Liposuction. A Multicenter Study of 845 Cases. Plast Reconstr Surg. 2021. PMID: 34644270. doi:10.1097/PRS.0000000000008577
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。